Martínez-Bosch and colleagues proved that PARP-1 upregulates MDM2, VEGFR1, and MMP28, accelerating tumor proliferation and angiogenesis in pancreatic cancer [42]. This evidence concerns the gene MDM2 and familial pancreatic carcinoma.